0001562180-18-000299.txt : 20180112
0001562180-18-000299.hdr.sgml : 20180112
20180112160759
ACCESSION NUMBER: 0001562180-18-000299
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180110
FILED AS OF DATE: 20180112
DATE AS OF CHANGE: 20180112
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kanes Stephen
CENTRAL INDEX KEY: 0001612859
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36544
FILM NUMBER: 18526069
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Sage Therapeutics, Inc.
CENTRAL INDEX KEY: 0001597553
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-299-8380
MAIL ADDRESS:
STREET 1: 215 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2018-01-10
false
0001597553
Sage Therapeutics, Inc.
SAGE
0001612859
Kanes Stephen
C/O SAGE THERAPEUTICS, INC.
215 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
Chief Medical Officer
Common Stock
2018-01-10
4
S
false
600.00
170.67
D
46348.00
D
Common Stock
2018-01-10
4
S
false
1200.00
171.80
D
45148.00
D
Common Stock
2018-01-10
4
S
false
1200.00
173.09
D
43948.00
D
Common Stock
2018-01-10
4
S
false
2200.00
174.35
D
41748.00
D
Common Stock
2018-01-10
4
S
false
2461.00
175.03
D
39287.00
D
Common Stock
2018-01-10
4
S
false
11057.00
176.53
D
28230.00
D
Common Stock
2018-01-10
4
S
false
9100.00
177.48
D
19130.00
D
Common Stock
2018-01-10
4
S
false
6923.00
178.33
D
12207.00
D
Common Stock
2018-01-10
4
S
false
7859.00
179.61
D
4348.00
D
Common Stock
2018-01-10
4
S
false
1400.00
180.11
D
2948.00
D
Common Stock
2018-01-12
4
M
false
20000.00
0.45
A
22948.00
D
Stock Option (Right to Buy)
0.45
2018-01-12
4
M
false
20000.00
0.00
D
2023-07-23
Common Stock
20000.00
111432.00
D
The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
This transaction was executed in multiple trades at prices ranging from $170.12 USD to $171.02 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $171.41 USD to $172.27 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $172.68 USD to $173.49 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $173.73 USD to $174.72 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $174.84 USD to $175.78 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $175.94 USD to $176.84 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $176.99 USD to $177.98 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $177.99 USD to $178.89 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $178.99 USD to $179.98 USD. The price reported above reflects the weighted average sale price.
This transaction was executed in multiple trades at prices ranging from $179.99 USD to $180.44 USD. The price reported above reflects the weighted average sale price.
The stock option award was issued pursuant to the Sage Therapeutics, Inc., 2011 Stock Option and Incentive Plan. The option fully vested on July 18, 2017, subject to continued service through such date.
/s/ Anne Marie Cook as Attorney-in-Fact for Stephen Kanes
2018-01-10